Enofelast
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161537This classification denotes an anti-asthmatic agent with the molecular formula C16H15FO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3T93TS0430, chemically known as 2,6-dimethyl-4-(2-(4-fluorophenyl)ethenyl)phenol but generally known as enofelast, which bears US NIH Compound Identifier 6439222. European Medicines Agency schedules Enofelast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06538MIG. The term ENOFELAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). ENOFELAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule enofelast under HS 29081900 and SITC 51244. As of Q4 2014, ENOFELAST remains the US FDA Preferred Term for this commodity. Enofelast bears US NLM identifiers UMLS ID C0091793 and NCI Concept Code C74134. SMILES: FC1CCC(/C=C/C2CC(C(O)C(C2)C)C)CC1.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.